ZYME - Company ID 0001937653
The table below shows Zymeworks Inc.'s balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash & equivalents | $41.16M | $66.10M | $157.56M | $400.91M |
| Short-term investments | - | - | $216.77M | $91.32M |
| Receivables | $4.64M | $55.81M | $19.48M | $33.40M |
| Inventory | - | - | - | - |
| Total current assets | $248.77M | $300.45M | $412.93M | $544.71M |
| Property, plant & equipment | $15.50M | $17.65M | $19.85M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $24.71M |
| Goodwill | $12.02M | $12.02M | $12.02M | $12.02M |
| Total assets | $346.53M | $463.09M | $580.88M | $648.73M |
| Accounts payable | - | - | - | - |
| Total current liabilities | $42.32M | $88.29M | $55.76M | $95.63M |
| Long-term debt | - | - | - | - |
| Total liabilities | $78.03M | $124.32M | $116.07M | $155.77M |
| Retained earnings | -$953.16M | -$830.34M | -$677.44M | -$558.76M |
| Total equity | $268.50M | $338.77M | $464.81M | $492.96M |